A gathering of the world’s thought leaders in medicine’s adaptive pathways to patients (MAPPs).
How can Europe proceed in the implementation of new development pathways and evidence generation to improve the access of needed new therapies to patients?
What are the current best practices, successes, and opportunities for the integration of patient data and analytics to improve patient outcomes and identify new medicines?
How can IMI2’s efforts and programmes under Horizon 2020 help European patients and healthcare providers?
Building on the EMA’s pilot project in adaptive pathways and the UK Government’s Support of a breakthrough designation, IMI, NewDigs and EFPIA will host this international conference to outline research and innovation in adaptive clinical pathways and patient data usage.